Search - tctmd.com

Displaying 21 - 40 of 104

Sort: Relevancy | Date

Presentation

Case Presentation - Pulmonary Edema and Mitral Regurgitation

Presenter: Igor Palacios

October 30, 2015

News Industry News

Early Human Cases With Edwards FORMA Tricuspid Repair System Presented At TCT

October 14, 2015

Presentation Aortovascular 2015

The Emergence of Pulmonary Embolism Response Teams (PERT)

Presenter: William A. Gray

September 18, 2015

Presentation Aortovascular 2015

Surgical Management of PE: Acute and subacute

Presenter: Matthew Bacchetta

September 18, 2015

Presentation Aortovascular 2015

An Algorithmic Management Strategy for Pulmonary Embolism

Presenter: Erika S. Berman-Rosenzweig

September 18, 2015

Presentation Aortovascular 2015

Acute Pulmonary Embolism: Diagnosis and risk stratification

Presenter: Philip Green

September 18, 2015

News Industry News

Acute Pulmonary Embolism Trial (SEATTLE II) Published in the JACC: Cardiovascular Interventions

August 24, 2015

News Daily News

肺动脉高压磨损可预测TAVR结果，可以帮助选择潜在适合者

Yael L. Maxwell

August 05, 2015

News Daily News

Pulmonary Hypertension Type Predicts TAVR Outcome, Could Help Select Candidates

Yael L. Maxwell

August 05, 2015

News Daily News

El Tipo de Hipertensión Pulmonar Predice el Resultado TAVR y Podría Ayudar a Seleccionar los Candidatos

Yael L. Maxwell

August 05, 2015

Presentation

Effect of Pulmonary Hypertension Hemodynamic Presentation on Clinical Outcomes in Pts With Severe Symptomatic Aortic Stenosis Undergoing TAVR

Presenter: CJ. O'Sullivan

August 04, 2015

Presentation CICT 2015

Percutaneous Pulmonary Valve Complications

Presenter: Ziyad M. Hijazi

July 31, 2015

News Industry News

Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix - BCM

July 27, 2015

News Daily News

肺栓塞发作后，二级抗凝效果未持续

L.A. McKeown

July 13, 2015

News Industry News

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

July 13, 2015

News Daily News

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

L.A. McKeown

July 13, 2015

News Daily News

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

L.A. McKeown

July 13, 2015

Presentation

6 Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism

Presenter: Francis Couturaud

July 10, 2015

News Industry News

Daiichi Sankyo gets EU OK for Lixiana anticoagulant

June 26, 2015

News Industry News

Idarucizumab Reverses the Anticoagulant Effect of Dabigatran Within Minutes in Patient Study

June 22, 2015

Advertisement

Case Presentation - Pulmonary Edema and Mitral Regurgitation

Early Human Cases With Edwards FORMA Tricuspid Repair System Presented At TCT

The Emergence of Pulmonary Embolism Response Teams (PERT)

Surgical Management of PE: Acute and subacute

An Algorithmic Management Strategy for Pulmonary Embolism

Acute Pulmonary Embolism: Diagnosis and risk stratification

Acute Pulmonary Embolism Trial (SEATTLE II) Published in the JACC: Cardiovascular Interventions

肺动脉高压磨损可预测TAVR结果，可以帮助选择潜在适合者

Pulmonary Hypertension Type Predicts TAVR Outcome, Could Help Select Candidates

El Tipo de Hipertensión Pulmonar Predice el Resultado TAVR y Podría Ayudar a Seleccionar los Candidatos

Effect of Pulmonary Hypertension Hemodynamic Presentation on Clinical Outcomes in Pts With Severe Symptomatic Aortic Stenosis Undergoing TAVR

Percutaneous Pulmonary Valve Complications

Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix - BCM

肺栓塞发作后，二级抗凝效果未持续

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

6 Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism

Daiichi Sankyo gets EU OK for Lixiana anticoagulant

Idarucizumab Reverses the Anticoagulant Effect of Dabigatran Within Minutes in Patient Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content